Michael Nedelcovych
Stock Analyst at TD Cowen
(1.52)
# 3,641
Out of 5,133 analysts
94
Total ratings
47.8%
Success rate
-0.2%
Average return
Main Sectors:
Stocks Rated by Michael Nedelcovych
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JNJ Johnson & Johnson | Reiterated: Buy | $300 | $285.75 | +4.99% | 4 | Oct 19, 2026 | |
| TYO: 4568 Daiichi Sankyo Company, Limited | Reiterated: Buy | ¥6,550 → ¥3,590 | ¥2,853 | +25.85% | 2 | Sep 28, 2026 | |
| NVO Novo Nordisk | Reiterated: Hold | $42 | $41.63 | +0.89% | 32 | Sep 22, 2026 | |
| RPRX Royalty Pharma | Rated: Buy | $65 → $68 | $69.31 | -1.89% | 11 | Sep 8, 2026 | |
| TSX: APTX Apotex Health Corp. | Initiated Coverage: Buy | $40.00 | $39.44 | +1.42% | 1 | Jul 6, 2026 | |
| TAK Takeda Pharmaceutical Company | Reiterated: Buy | $21 | $21.43 | -2.01% | 14 | Jun 4, 2026 | |
| CHRS Coherus Oncology | Reiterated: Buy | n/a | $0.5255 | - | 13 | May 28, 2026 | |
| TSX: BHC Bausch Health Companies Inc. | Reiterated: Hold | $9.93 | $11.91 | -16.60% | 9 | Apr 30, 2026 | |
| SWX: MOLN Molecular Partners AG | Reiterated: Buy | CHF 15.00 | CHF 2.40 | +525.00% | 6 | Mar 16, 2026 | |
| TYO: 4502 Takeda Pharmaceutical Company Limited | Reiterated: Buy | ¥5,135 | ¥6,926 | n/a | 1 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $2.94 | n/a | 1 | Mar 14, 2025 |
Johnson & Johnson
Oct 19, 2026
Reiterated: Buy
Price Target: $300
Current: $285.75
Upside: +4.99%
Daiichi Sankyo Company, Limited
Sep 28, 2026
Reiterated: Buy
Price Target: ¥6,550 → ¥3,590
Current: ¥2,853
Upside: +25.85%
Novo Nordisk
Sep 22, 2026
Reiterated: Hold
Price Target: $42
Current: $41.63
Upside: +0.89%
Royalty Pharma
Sep 8, 2026
Rated: Buy
Price Target: $65 → $68
Current: $69.31
Upside: -1.89%
Apotex Health Corp.
Jul 6, 2026
Initiated Coverage: Buy
Price Target: $40.00
Current: $39.44
Upside: +1.42%
Takeda Pharmaceutical Company
Jun 4, 2026
Reiterated: Buy
Price Target: $21
Current: $21.43
Upside: -2.01%
Coherus Oncology
May 28, 2026
Reiterated: Buy
Price Target: n/a
Current: $0.5255
Upside: -
Bausch Health Companies Inc.
Apr 30, 2026
Reiterated: Hold
Price Target: $9.93
Current: $11.91
Upside: -16.60%
Molecular Partners AG
Mar 16, 2026
Reiterated: Buy
Price Target: CHF 15.00
Current: CHF 2.40
Upside: +525.00%
Takeda Pharmaceutical Company Limited
May 21, 2025
Reiterated: Buy
Price Target: ¥5,135
Current: ¥6,926
Upside: n/a
Mar 14, 2025
Reiterated: Buy
Price Target: $17
Current: $2.94
Upside: n/a